The In Vitro Inhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine

The purpose of this study was to investigate the in vitro inhibition potential of the three purified herbal constituents tetrahydropalmatine (Tet), neferine (Nef) and berberine (Ber) towards recombinant human CYP1A2, CYP2D6 and CYP3A4 metabolic activities. In vitro incubations were performed with phenacetin, dextromethorphan and testosterone, respectively, as CYP substrates and their metabolites were determined by validated HPLC methods. Positive control inhibitors were run for each CYP in all incubation series. Inhibition was expressed by IC50 values. All herbal constituents demonstrated some, but variable, inhibition potencies towards the investigated CYP enzymes. CYP2D6 was the most sensitive for inhibition and then mainly by Tet and Ber with IC50 values of 3.04 ± 0.26 µm and 7.40 ± 0.36 µm, respectively. CYP3A4 and especially CYP1A2 were inhibited to a much smaller extent by all constituents. Neferine showed the lowest overall interaction potential towards the CYP enzymes investigated. The CYP inhibition potential for the purified constituents could be related to their chemical structures. No clinical significant metabolic interaction seems likely to occur between the CYP enzymes and herbal constituents tested, with a possible exception for the CYP2D6 inhibition by Tet and Ber. Copyright © 2011 John Wiley & Sons, Ltd.

[1]  O. G. Nilsen,et al.  [Interaction between four herb compounds and a western drug by CYP3A4 enzyme metabolism in vitro]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[2]  Yi Liu,et al.  Investigation of the interaction between Berberine and human serum albumin. , 2009, Biomacromolecules.

[3]  Z. Zuo,et al.  [Inhibition of human cytochrome P-450 CYP1A2 by flavonoids: a quantitative structure-activity relationship study ]. , 2008, Yao xue xue bao = Acta pharmaceutica Sinica.

[4]  Guo-liang Zhang,et al.  Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  S. Kadota,et al.  In Vitro Mechanism-Based Inactivation of Cytochrome P450 3A4 by a New Constituent of Cinnamomum burmani , 2008, Planta medica.

[6]  Ji-Hong Liu,et al.  Effects of plant extract neferine on cyclic adenosine monophosphate and cyclic guanosine monophosphate levels in rabbit corpus cavernosum in vitro. , 2008, Asian journal of andrology.

[7]  Bonnie K. Lind,et al.  Potential Interactions Between Complementary/Alternative Products and Conventional Medicines in a Medicare Population , 2007, The Annals of pharmacotherapy.

[8]  Xiaoming Wang,et al.  Improved RP-HPLC method to determine neferine in dog plasma and its application to pharmacokinetics. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Jialing Wang,et al.  Pharmacokinetics and metabolism of neferine in rats after a single oral administration , 2007, Biopharmaceutics & drug disposition.

[10]  P. Neuvonen,et al.  Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation , 2007, European Journal of Clinical Pharmacology.

[11]  Z. Hong,et al.  Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of tetrahydropalmatine enantiomers in dogs. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  H. Iwata,et al.  IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT , 2004, Drug Metabolism and Disposition.

[13]  Jianguo Cao,et al.  Multidrug resistance reversal in human gastric carcinoma cells by neferine. , 2004, World journal of gastroenterology.

[14]  J. Brockmöller,et al.  The Induction of Cytochrome P450 3A5 (CYP3A5) in the Human Liver and Intestine Is Mediated by the Xenobiotic Sensors Pregnane X Receptor (PXR) and Constitutively Activated Receptor (CAR)* , 2004, Journal of Biological Chemistry.

[15]  Magnus Ingelman-Sundberg,et al.  Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. , 2004, Trends in pharmacological sciences.

[16]  P. Chatterjee,et al.  Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Amy Roe,et al.  The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[18]  D. Shen,et al.  Comparison of CYP2D6 Content and Metoprolol Oxidation Between Microsomes Isolated from Human Livers and Small Intestines , 1999, Pharmaceutical Research.

[19]  D. Dunbar,et al.  Characterization of human small intestinal cytochromes P-450. , 1999, Drug Metabolism And Disposition.

[20]  E. Ernst.  Harmless herbs? A review of the recent literature. , 1998, The American journal of medicine.

[21]  Slobodan Petar Rendic,et al.  Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. , 1997, Drug metabolism reviews.

[22]  F. Guengerich,et al.  Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. , 1993, Journal of medicinal chemistry.

[23]  Zhang Rui-sheng.  The therapeutic effects of combination of simvastatin with berberine on the patients with hyperlipemia , 2009 .

[24]  Jiang Jian-dong.  Progress in pharmacokinetic researches of berberine , 2008 .

[25]  O. G. Nilsen,et al.  The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. , 2007, Basic & clinical pharmacology & toxicology.

[26]  W. Xiao.  The Pharmacokinetics of Enhancement of Cyclosporin A by Berberine Chloride Coadministrated in Renal Transplanted Recipients , 2001 .